Home
Understanding PD
Definition of PD
Prevalence of PD
Impact on quality of life
Pathophysiology of PD
Clinical presentation
Motor symptoms of PD
Non-motor symptoms of PD
Diagnosis of PD
Scales and scores for assessing PD symptoms
Pharmacological treatment options for PD
Pharmacological treatment options
Dopaminergic agents
Treatment decision pathway
Visual library
Mirapexin
®
/Sifrol
®
(pramipexole)
General introduction
Mechanism of action
Clinical evidence
Motor symptoms
Non-motor symptoms
Ongoing research
References
Congresses & media events
International congress schedule
Media events
Glossary
Contact
Sitemap
Sitemap
Home
Understanding PD
Definition of PD
Prevalence of PD
Impact on quality of life
Pathophisiology of PD
Clinical presentation
Motor symptoms of PD
Non-motor symptoms of PD
Diagnosis of PD
Scales and scores for assessing PD symptoms
Pharmacological treatment options for PD
Pharmacological treatment options
Dopaminergic agents
Treatment decision pathway
Visual library
Mirapexin
®
/ Sifrol
®
(pramipexole)
General introduction
Mechanism of action
Clinical evidence
Motor symptoms
Non-motor symptoms
Ongoing research
References
Congresses & media events
International congress schedule
Media events
Glossary
About Boehringer Ingelheim
Terms of use
Imprint
Contact
Home
|
Understanding PD
|
Mirapexin
®
/Sifrol
®
(pramipexole)
|
References
|
Congresses & media events
|
Glossary
About Boehringer Ingelheim
|
Terms of use
|
Imprint
|
Contact
|
Sitemap
© 2009 Boehringer Ingelheim GmbH. All rights reserved. Last updated: October 2009